Product correctly added to cart.

discount label
Tofacitinib impurity L
View 3D

TRC logo

Tofacitinib impurity L

CAS: 1675248-19-7

Ref. TR-T528015

10mg
1,091.00 €
25mg
1,954.00 €
2500µg
296.00 €
Estimated delivery in United States, on Tuesday 14 Jan 2025

Product Information

Name:
Tofacitinib impurity L
Controlled Product
Synonyms:
  • (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ß-oxo-1-piperidinepropanamide
  • Tofacitinib Citrate Impurity 05
Description:

Impurity Tofacitinib Impurity (T528000)
Applications Tofacitinib impurity L is an impurity of Tofacitinib (T528000), an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
References Jiang, J., et. al.: J. med. Chem., 51, 8012 (2008)

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:

Chemical properties

Molecular weight:
330.38
Formula:
C16H22N6O2
Color/Form:
Neat
InChI:
InChI=1S/C16H22N6O2/c1-10-4-6-22(14(24)7-13(17)23)8-12(10)21(2)16-11-3-5-18-15(11)19-9-20-16/h3,5,9-10,12H,4,6-8H2,1-2H3,(H2,17,23)(H,18,19,20)/t10-,12+/m1/s1
InChI key:
InChIKey=CRDMXSMPTHMXRD-PWSUYJOCSA-N
SMILES:
C[C@@H]1CCN(C(=O)CC(N)=O)C[C@@H]1N(C)c1ncnc2[nH]ccc12
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TR-T528015 Tofacitinib impurity L

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".